Skip to main content
SpringerLink
Log in

Health-related quality of life in endstage renal failure

  • Research Papers
  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

The objective of this study was to describe the health-related quality of life (HRQOL) of patients on different forms of treatment for endstage renal failure in such a way that the data could be used in a cost-utility analysis of renal failure treatment in Britain. Twenty-four British renal units participated in this study. 997 adult dialysis and transplant patients were randomly selected from these units using the European Dialysis and Transplant (EDTA) Registry Database. The Health Measurement Questionnaire was compieted by 705 of the 900 patients who were alive at the time of the survey (response rate of 78%). The HRQOL data were linked with comorbidity data and with clinical data from the EDTA Registry. Compared to the general population, patients with endstage renal failure experienced a lower quality of life. Many factors contributed to this, but uncertainty about the future and lack of energy emerged as key components. Transplant recipients reported better HRQOL than dialysis patients, they reported fewer problems with physical mobility, self-care, social and personal relationships and usual activities. They also experienced significantly less distress, while dialysis patients reported problems with depression, anxiety, pain and uncertainty about the future. These differences remained after controlling for age and comorbidity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bremer BA, McCauley CR, Wrona RM, Johnson JP. Quality of life in end-stage renal failure: a reexamination.Am J Kidney Dis 1989;13(3: 200–209.

    Google Scholar 

  2. Evans RW, Manninen DL, Garrison LP, et al. The quality of life of patients with end-stage renal disease.N Engl J Med 1985;312(9: 553–559.

    Google Scholar 

  3. Oldenburg B, MacDonald GJ, Perkins RJ. Prediction of quality of life in a cohort of end-stage renal disease patients.J Clin Epidemiol 1988;41(6: 555–564.

    Google Scholar 

  4. Kutner NG, Brogan D, Kutner MH. End-stage renal disease treatment modality and patients' quality of life.Am J Nephrol 1986;6: 396–402.

    Google Scholar 

  5. Parfrey PS, Vavasour H, Bullock M, et al. Development of a health questionnaire specific for end-stage renal disease.Nephron 1989;52: 20–28.

    Google Scholar 

  6. Simmons RG, Abress L, Anderson CR. Quality of life after kidney transplantation.Transplantation 1988;45: 415–421.

    Google Scholar 

  7. Fox E, Peace K, Neale TJ, et al. Quality of life for patients with end-stage renal failure.Renal Failure 1991;13(1: 31–35.

    Google Scholar 

  8. Churchill DN, Torrance GW, Taylor DW, et al. Measurement of quality of life in end-stage renal disease: the time trade-off approach.Clin Invest Med 1987;10(1: 14–20.

    Google Scholar 

  9. Christensen AJ, Holman JM Jr, Turner CW, et al. A prospective study of quality of life in end-stage renal disease: effects of cadaveric renal transplantation.Clin Transplantation 1991;5: 40–47.

    Google Scholar 

  10. Auer J, Oliver DO, Winearls CG. The quality of life of dialysis patients treated with recombinant human erythropoietin.Scand J Urol Nephrol 1990;131 (Suppl: 61–65.

    Google Scholar 

  11. Stevens ME, Summerfield GP, Hall AA, et al. Cost benefits of low dose subcutaneous erythropoietin in patients with anaemia of end stage renal disease.Br Med J 1992;304: 474–477.

    Google Scholar 

  12. Laupacis A, Muirhead N, Keown P, Wong C. A disease-specific questionnaire for assessing quality of life in patients on hemodialysis.Nephron 1992;60: 302–306.

    Google Scholar 

  13. Klarman HE, Francis JO, Rosenthal GD. Cost effectiveness analysis applied to the treatment of chronic renal disease.Med Care 1968;6: 48–54.

    Google Scholar 

  14. Ludbrook A. A cost-effectiveness analysis of the treatment of chronic renal failure.Applied Economics 1981;13: 337–350.

    Google Scholar 

  15. Harris D. Low-dosage epoetin in maintenance haemodialysis.Pharmaco Economics 1994;5: 18–28.

    Google Scholar 

  16. Leese B, Hutton J, Maynard A. A comparison of the costs and benefits of recombinant human erythropoietin (epoetin) in the treatment of chronic renal failure in 5 European countries.Pharmaco Economics 1992;1: 346–356.

    Google Scholar 

  17. de Charro FT, Gudex C, Feest TG,et al. Statistical projections and scenario forecasts of the adult British endstage renal failure programme.

  18. Rosser R, Kind P. A scale of valuations of states of illness: is there a social consensus?Int J Epidemiol 1978;7(4: 347–358.

    Google Scholar 

  19. Gudex C, Kind P.The QALY Toolkit. Centre for Health Economics, University of York, 1988. [Discussion paper 38].

  20. Kind P, Gudex C. Measuring health status in the community: a comparison of methods.J Epidemiol Comm Health 1994;48(1: 86–91.

    Google Scholar 

  21. Dixon A, Southern JP, Teale A, et al. Magnetic resonance imaging of the head and spine: effective for the clinician or the patient?Br Med J 1991;302: 79–82.

    Google Scholar 

  22. Gater RA, Kind P, Gudex C. Quality of life in liaison psychiatry: a comparison of patient and clinician assessment.Br J Psych 1995;166: 515–520.

    Google Scholar 

  23. Magee TR, Scott DJ, Dunkley A, et al. Quality of life following surgery for abdominal aortic aneurysm.Br J Surg 1992;79: 1014–1016.

    Google Scholar 

  24. Pedersen KV, Carlsson P, Rahmquist M, Varenhorst E. Quality of life after radical retropubic prostatectomy for carcinoma of the prostate.Eur Urol 1993;24: 7–11.

    Google Scholar 

  25. Ridley SA, Wallace P. Quality of life after intensive care.Anaesthesia 1990;45: 808–813.

    Google Scholar 

  26. Unsworth-White J, Kallis P, Treasure T, Papper J. Quality of life after cardiac surgery in patients over 70 years of age.Cardiol Elderly 1994;2: 133–138.

    Google Scholar 

  27. Whynes DK, Neilson AR. Convergent validity of two measures of the quality of life.Health Econ 1993;2: 229–235.

    Google Scholar 

  28. Gudex C, Kind P, van Dalen H,et al. Comparing scaling methods for health state valuations—Rosser revisited. Centre for Health Economics, University of York, 1993. [Discussion paper 107].

  29. Hornberger JC, Redelmeier DA, Petersen J. Variability among methods to assess patients' well-being and consequent effect on a cost-effectiveness analysis.J Clin Epidemiol 1992;45: 505–512.

    Google Scholar 

  30. Wing AJ, Broyer M, Brunner FP. Demography of dialysis and transplantation in Europe in 1985 and 1986: trends over the last decade.Nephrol Dial Transplant 1988;3: 714–727.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre for Health Economics, University of York, YO1 5DD, York, UK

    C. M. Gudex

Authors
  1. C. M. Gudex
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gudex, C.M. Health-related quality of life in endstage renal failure. Qual Life Res 4, 359–366 (1995). https://doi.org/10.1007/BF01593889

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01593889

Key words

Search

Navigation